Manufacturing & Research Sites

Where Research Meets Production, and Innovation Transforms Into Patient Care

At Arena Life Science, our strength lies in the combination of advanced manufacturing facilities and dedicated research centers. These sites are the foundation of our innovation, ensuring that every product we deliver meets the highest standards of quality, safety, and scientific excellence.

Manufacturing Facilities

State-of-the-Art Production Units

Our manufacturing sites are equipped with modern pharmaceutical technologies and operate under strict Good Manufacturing Practices (GMP). These facilities enable us to produce a wide range of medicines, including:

  • Cardiovascular treatments – Rivaroxaban (Axabin), Apixaban (Apirax).
  • Diabetes medicines – Sitagliptin (Diaptin).
  • Autoimmune therapies – Leflunomide (Lerava).
  • Biotechnology products – Recombinant proteins and advanced biologics.

Quality Assurance

Each facility is designed with a robust quality control system, ensuring that all medicines are manufactured in compliance with IFDA regulations and international pharmaceutical standards.

Global-Presence-Img

Research & Development Centers

Innovation Hub

Arena Life Science’s R&D centers are the driving force behind our scientific breakthroughs. Our teams focus on:

  • Development of complex generics and biologics.
  • Advanced studies in recombinant protein therapies, such as Alteplase.
  • Clinical research, supported by scientific documentation and regulatory approvals.

Knowledge-Based Recognition

Since 2016, Arena Life Science has been officially recognized as a Knowledge-Based Company, a testament to the strength of our research, innovation, and technological advancements.

Integration of Research & Manufacturing

What makes Arena unique is the synergy between research and production:

From lab to market

Our R&D results are seamlessly transferred into manufacturing, ensuring faster and more efficient product launches.

Continuous improvement

Feedback from production informs ongoing research, enhancing innovation and efficiency.

Collaboration

Scientists, engineers, and regulatory experts work together to bring cutting-edge medicines to patients.

Our Future Focus

  • Expansion of biotechnology facilities to support large-scale production of complex biologics.
  • Investment in digital and smart manufacturing systems for efficiency and sustainability.
  • Strengthening collaborations with global research institutions to drive pharmaceutical innovation.